Page 36 - Central Drug Authority Annual Report 2021

7KH &RORPER 3ODQ LV RQH RI WKH ROGHVW LQWHUJRYHUQPHQWDO
,6683 LPSOHPHQWV LWV DFWLYLWLHV LQ FRQVXOWDWLRQ ZLWK
&DQDGLDQ &HQWUH RQ 6XEVWDQFH $EXVH &&6$
&RORPER 3ODQ
&RRSHUDWLRQ 3URJUDPPH RQ 'UXJV 3ROLFLHV &232/$'
(XURSHDQ 0RQLWRULQJ &HQWUH IRU 'UXJV DQG 'UXJ
$GGLFWLRQ (0&''$
(XURSHDQ 6RFLHW\ IRU 3UHYHQWLRQ 5HVHDUFK (8635
2UJDQLVDWLRQ RI $PHULFDQ 6WDWHV ,QWHU $PHULFDQ 'UXJ
Abuse Control Commission (
6RFLHW\ IRU 3UHYHQWLRQ 5HVHDUFK 635
7KH (XURSHDQ 3UHYHQWLRQ 6WDQGDUGV 3DUWQHUVKLS
8QLWHG 1DWLRQV 2IˉFH RQ 'UXJV DQG &ULPH 812'&
8 6 'HSDUWPHQW RI 6WDWHȠV %XUHDX RI ,QWHUQDWLRQDO
1DUFRWLFV DQG /DZ (QIRUFHPHQW $IIDLUV ,1/
:RUOG +HDOWK 2UJDQLVDWLRQ :+2
34 Annual R epor t 2020/2021 C entral Drug Authority
Annual Report 2020/2021 Central Drug Authority
2.9 INTERNATIONAL NETWORK ON HEPATITIS IN
SUBSTANCE USERS (INHSU)
,1+68 LV DQ LQWHUQDWLRQDO RUJDQLVDWLRQ GHGLFDWHG WR
VFLHQWLˉF NQRZOHGJH H[FKDQJH NQRZOHGJH WUDQVODWLRQ DQG
DGYRFDF\ IRFXVHG RQ KHSDWLWLV & SUHYHQWLRQ DQG FDUH IRU
SHRSOH ZKR XVH GUXJV ,QFUHDVLQJ KHSDWLWLV & WHVWLQJ OLQNDJH
to care, treatment and cure among people who use drugs is
RI SDUDPRXQW LPSRUWDQFH 7KLV LV DQ LQLWLDWLYH WKDW WKH &'$
VXSSRUWV
7KH H[WHQW WR ZKLFK WKH &'$ ZDV DEOH WR H[SORUH DQG H[SORLW
WKHVH SDUWQHUVKLSV DQG UHODWLRQVKLSV KDV QRW EHHQ RSWLPDO
,QGLYLGXDO GHSDUWPHQWV ZHUH KRZHYHU DEOH WR IRUJH
relationships and interact with these agencies in line with
VHFWRU SROLFLHV DQG VHUYLFH GHOLYHU\ PDQGDWHV DV LQGLFDWHG LQ
WKH GHSDUWPHQWDO DQG VHFWRU UHSRUWV EHORZ
LQLWLDWLYHV LQ WKH $VLDQ 3DFLˉF 5HJLRQ DQG ZDV RIˉFLDOO\
JHDUHG WRZDUGV SURYLGLQJ WKRVH GHSHQGHQW RQ GUXJV ZLWK D
ODXQFKHG E\ $XVWUDOLD &DQDGD ,QGLD 3DNLVWDQ 1HZ =HDODQG
ȟVHFRQG FKDQFHȠ WR OLYLQJ D OLIH RI TXDOLW\ 7KH SURJUDPPH LV
6UL /DQND DQG WKH 8QLWHG .LQJGRP LQ
WKHUHIRUH FDOOHG WKH 6HFRQG &KDQFH 3URJUDPPH
1) Aims and Objectives of The Colombo Plan
Programme for the Public Administration and Environment:
7KH DFWLYLWLHV RI WKLV SURJUDPPH IRFXV RQ FOLPDWH FKDQJH
ȧ 7R SURPRWH LQWHUHVW LQ VXSSRUW RI HFRQRPLF DQG VRFLDO
DQG WKH HPSRZHUPHQW RI ZRPHQ /RQJ WHUP 6FKRODUVKLSV
GHYHORSPHQW LQ PHPEHU VWDWHV
3URJUDPPH 7KLV SURJUDPPH SURYLGHV VFKRODUVKLSV WR WKRVH
ȧ 7R SURPRWH WHFKQLFDO FR RSHUDWLRQ DQG WKH VKDULQJ RI
LQ QHHG
technology among member states, and
• 7R UHYLHZ WKH UHOHYDQW LQIRUPDWLRQ ,W DOVR DLPV WR
2.8 ISSUP GLOBAL
IDFLOLWDWH WKH WUDQVIHU DQG VKDULQJ RI GHYHORSPHQW
experiences among member countries, especially
WKRVH LQ WKH VRXWKHUQ KHPLVSKHUH
,6683 *OREDO ZDV LQLWLDWHG LQ WKURXJK ,1/ ZRUNLQJ LQ
FRQVXOWDWLRQ ZLWK WKH $IULFDQ 8QLRQ 2$6 &,&$' &RORPER
3ODQ 812'& DQG :+2 ,W ZDV HVWDEOLVKHG LQ WKH 8QLWHG
2) Programmes of Colombo Plan
.LQJGRP DV D QRW IRU SURˉW FRPSDQ\ OLPLWHG E\ JXDUDQWHH LQ
7KH IRXU SHUPDQHQW SURJUDPPHV FDUULHG RXW E\ WKH &RORP-
)HEUXDU\ ,W LV D XQLTXH LQLWLDWLYH RIIHULQJ DQ LQWHUQD-
ER 3ODQ DUH
tional and credible professional membership that brings
WRJHWKHU ERWK WKH WUHDWPHQW DQG SUHYHQWLRQ ZRUNIRUFH
7KH 'UXJ $GYLVRU\ 3URJUDPPH '$3
concerned with substance abuse,
7KH 3URJUDPPH IRU 3XEOLF $GPLQLVWUDWLRQ DQG
(QYLURQPHQW DQG 7KH 3URJUDPPH IRU
7KH ,6683 DLPV WR SURYLGH SURIHVVLRQDOV ZRUNLQJ LQ SXEOLF
3ULYDWH 6HFWRU 'HYHORSPHQW DQG WKH /RQJ WHUP
WUHDWPHQW FHQWUHV DQG SUHYHQWLRQ ˉHOGV ZLWK WUDLQLQJ WR
6FKRODUVKLSV 3URJUDPPH
HTXLS WKHP ZLWK VNLOOV DQG NQRZOHGJH WR FRPEDW 6XEVWDQFH
8VH 'LVRUGHUV ,W HQDEOHV WKHVH SURIHVVLRQDOV WR DSSO\
3) The Link between the CDA and the Colombo Plan
VFLHQFH PDNLQJ LW DFFHVVLEOH DQG FRPSUHKHQVLEOH IRU HYHU\-
7KH &'$ KDV VXSSRUWHG WKH &RORPER 3ODQ LQLWLDWLYHV
RQH ZLWKLQ WKH LQWHUQDWLRQDO GUXJ WUHDWPHQW DQG SUHYHQWLRQ
SURJUDPPHV DQG WUDLQLQJ VHVVLRQV ZLWKLQ 6RXWK $IULFD 2QFH
FRPPXQLW\ ,W LV DOVR SURIHVVLRQDOLVLQJ WKH SUHYHQWLRQ DQG
DFFUHGLWHG E\ WKH 6RXWK $IULFDQ 4XDOLˉFDWLRQV $XWKRULW\
treatment workforce, to promote quality standards, ethical,
6$4$ WKH YDULRXV SURJUDPPHV VKRXOG EH YDOXDEOH WRROV LQ
DQG HYLGHQFH EDVHG SUDFWLFH ,W LV DQ LQWHUQDWLRQDO RUJDQLVD-
WKH &'$ȠV HIIRUWV WR VWUHQJWKHQ LWV VXSSRUW VWUXFWXUHV 36$)V
tion that was set up to meet the needs and challenges faced
DQG /'$&V
E\ WKH SUHYHQWLRQ DQG WUHDWPHQW ZRUNIRUFH
The key characteristics of these programmes are as follows:
)LQDOO\ SUHYHQWLRQ DQG WUHDWPHQW VFLHQFH KDV PRYHG
Drug Advisory Programme (DAP): 7KLV SURJUDPPH DLPV WR
VXEVWDQWLDOO\ RYHU UHFHQW \HDUV 7KH IROORZLQJ DUH WKH UHFHQW
build capacity for drug demand reduction in the Asian and
FRXUVHV WKDW DUH DLPHG DW SURYLGLQJ SURIHVVLRQDOV ZLWK
3DFLˉF 5HJLRQ ,W HQFRXUDJHV QDWLRQDO HIIRUWV DPRQJ
continuing education and sharpening their skills and knowl-
PHPEHU FRXQWULHV WRZDUGV GHPDQG UHGXFWLRQ '$3 LQLWLD-
HGJH LQ WKH ˉHOG
WLYHV LQFOXGH WKH HVWDEOLVKPHQW RI QDWLRQDO GUXJ IRFDO
8QLYHUVDO 3UHYHQWLRQ &XUULFXOXP
points, the formulation of national drug policy, the imple-
8QLYHUVDO 7UHDWPHQW &XUULFXOXP
PHQWDWLRQ RI GUXJ GHPDQG UHGXFWLRQ LQLWLDWLYHV WKH LQLWLD-
,W LV LPSRUWDQW WR VWDWH WKDW WKH FRXUVHV DERYH ZHUH VXSSRUW-
WLRQ RI WKH $IJKDQ GUXJ GHPDQG UHGXFWLRQ LQLWLDWLYH DQG WKH
HG E\ ,1/ DQG WKH &RORPER 3ODQ
$VLDQ &HQWUH IRU &HUWLˉFDWLRQ DQG (GXFDWLRQ RI $GGLFWLRQ
3URIHVVLRQDOV $&&(
7KH (XURSHDQ 'UXJ 3UHYHQWLRQ 4XDOLW\ 6WDQGDUGV LV IXQGHG
E\ WKH (XURSHDQ 8QLRQ DQG XQGHUWDNHQ E\ WKH (XURSHDQ
The ACCE initiatives ZHUH HVWDEOLVKHG LQ DV WKH
3UHYHQWLRQ 6WDQGDUGV 3DUWQHUVKLS DQG WKH ,QWHUQDWLRQDO
WUDLQLQJ DQG FUHGHQWLDOLQJ DUP RI WKH '$3 7KH $&&( LV DQ
6WDQGDUGV RQ 'UXJ 8VH 3UHYHQWLRQ SURGXFHG E\ 812'&
LQWHJUDO SDUW RI WKH JOREDO LQLWLDWLYH IXQGHG E\ WKH %XUHDX
IRU ,QWHUQDWLRQDO 1DUFRWLFV DQG /DZ (QIRUFHPHQW $IIDLUV RI
WKH 86 'HSDUWPHQW RI 6WDWH
2.7 THE COLOMBO PLAN Programme for the Private Sector: 7KLV SURJUDPPH LV